| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO | Director | CEO
1 company
Collier Alan Brian is a CEO at ENDONOVO THERAPEUTICS, INC.. Recent SEC Form 4 filings include 157 buys and 0 sells.
Estimated insider holdings value: $3 based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 10, 2019 | ENDV Endonovo Therapeutics, Inc. | CEO | Buy | 183,774 | $0.01 | $2,174.88 | - | |
| May 6, 2019 | ENDV Endonovo Therapeutics, Inc. | CEO | Buy | 255,000 | $0.01 | $2,858.93 | - | |
| May 2, 2019 | ENDV Endonovo Therapeutics, Inc. | CEO | Buy | 179,000 | $0.01 | $1,974.00 | - | |
| Apr 29, 2019 | ENDV Endonovo Therapeutics, Inc. | CEO | Buy | 40,000 | $0.01 | $596.10 | - | |
| Apr 25, 2019 | ENDV Endonovo Therapeutics, Inc. | CEO | Buy | 57,000 | $0.01 | $673.20 | - | |
| Apr 24, 2019 | ENDV Endonovo Therapeutics, Inc. | CEO | Buy | 48,000 | $0.01 | $675.80 | - | |
| Apr 12, 2019 | ENDV Endonovo Therapeutics, Inc. | CEO | Buy | 13,500 | $0.02 | $230.20 | - | |
| Apr 3, 2019 | ENDV Endonovo Therapeutics, Inc. | CEO | Buy | 36,000 | $0.02 | $632.20 | - | |
| Mar 27, 2019 | ENDV Endonovo Therapeutics, Inc. | CEO | Buy | 54,000 | $0.02 | $983.40 | - | |
| Mar 21, 2019 | ENDV Endonovo Therapeutics, Inc. | CEO | Buy | 43,000 | $0.02 | $826.65 | - |